Lyell Immunopharma Expansion is Underway in Bothell
Cellular therapy company Lyell Immunopharma is investing $50 million in a new 70,000 square foot manufacturing facility located in Bothell, Washington. This investment will support multiple clinical programs and eventual scale-up of manufacturing to meet late stage clinical development needs.
PHOTO: Stephen Hill, Lyell Immunopharma’s Chief Technical Operations Officer (courtesy Lyell Immunopharma)